Pat Soon-Shiong, Executive Chairman at ImmunityBio, shared on X:
“Exciting to see that finally that big pharma has woken to the race to find a cancer vaccine. What is needed is the Personalized mutations that make up the components of that vaccine…and we began that quest since 2015 at Nantomics!
Now the fundamental computing methods have been established and tons of IP claims have been issued…connecting the dots on the Nant cancer vaccine .. a decade of work coming to fruition.
Will send a flow of connecting Nant dots next. In the meantime go to NantOmics.com and look under publications….patents coming next.”
Other articles featuring Pat Soon-Shiong on OncoDaily.